APA

Sabnani I., Zucker M. J., Rosenstein E. D., Baran D. A., Arroyo L. H., Tsang P., Zubair M. & Rivera V. (20090225). A novel therapeutic approach to the treatment of scleroderma-associated pulmonary complications: safety and efficacy of combination therapy with imatinib and cyclophosphamide. : Rheumatology (Oxford, England).

Chicago

Sabnani I, Zucker M J, Rosenstein E D, Baran D A, Arroyo L H, Tsang P, Zubair M and Rivera V. 20090225. A novel therapeutic approach to the treatment of scleroderma-associated pulmonary complications: safety and efficacy of combination therapy with imatinib and cyclophosphamide. : Rheumatology (Oxford, England).

Harvard

Sabnani I., Zucker M. J., Rosenstein E. D., Baran D. A., Arroyo L. H., Tsang P., Zubair M. and Rivera V. (20090225). A novel therapeutic approach to the treatment of scleroderma-associated pulmonary complications: safety and efficacy of combination therapy with imatinib and cyclophosphamide. : Rheumatology (Oxford, England).

MLA

Sabnani I, Zucker M J, Rosenstein E D, Baran D A, Arroyo L H, Tsang P, Zubair M and Rivera V. A novel therapeutic approach to the treatment of scleroderma-associated pulmonary complications: safety and efficacy of combination therapy with imatinib and cyclophosphamide. : Rheumatology (Oxford, England). 20090225.